Related references
Note: Only part of the references are listed.Letter to the editor: Are clinical practice guidelines for hepatitis C by the American Association for the Study of Liver Diseases and Infectious Diseases Society of America evidence based? Financial conflicts of interest and assessment of quality of evidence and strength of recommendations
Anju Murayama et al.
HEPATOLOGY (2022)
Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017
Kayo Harada et al.
HEALTH POLICY (2021)
Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment
Futa Kida et al.
LIVER INTERNATIONAL (2021)
Strength of Recommendation and Quality of Evidence for Recommendations in Current Infectious Diseases Society of America Guidelines
Kaitlin E. Miles et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Self-reported Financial Conflict of Interest in Nephrology Clinical Practice Guidelines
Madhuri Chengappa et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis
Liang Yao et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan
Kana Yamamoto et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2021)
Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016
Akihiko Ozaki et al.
HEALTH POLICY (2020)
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
Anju Murayama et al.
PLOS ONE (2020)
Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review
Camilla H. Nejstgaard et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018
Alexander C. Fanaroff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
Ray Moynihan et al.
BMJ OPEN (2019)
CJASN and Disclosure of Conflicts of Interest
Rajnish Mehrotra
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Financial Conflicts of Interest Among Authors of Clinical Practice Guidelines for Routine Screening Mammography
Tyler Combs et al.
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2019)
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines
Ramy R. Saleh et al.
CANCER (2019)
Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan
H. Saito et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
Akihiko Ozaki et al.
BMJ OPEN (2019)
A systematic breakdown of the levels of evidence supporting the European Society of Cardiology guidelines
Wouter B. van Dijk et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
Hiroaki Saito et al.
JAMA NETWORK OPEN (2019)
Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016
Yuki Shimada et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Conflicts of Interest in Clinical Guidelines: Update of US Preventive Services Task Force Policies and Procedures
Quyen Ngo-Metzger et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2018)
The Evidence Basis for the American College of Rheumatology Practice Guidelines
Ali Duarte-Garcia et al.
JAMA INTERNAL MEDICINE (2018)
Conflict of Interest in Seminal Hepatitis C Virus and Cholesterol Management Guidelines
Akilah A. Jefferson et al.
JAMA INTERNAL MEDICINE (2017)
Association of Gender With Financial Relationships Between Industry and Academic Otolaryngologists
Jean Anderson Eloy et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
Evidence Underlying KDIGO (Kidney Disease: Improving Global Outcomes) Guideline Recommendations: A Systematic Review
Mohamed Alseiari et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Wales approves new hepatitis C drug while England deliberates
Piotr Ozieranski et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study
Paul Campsall et al.
PLOS MEDICINE (2016)
Wales approves new hepatitis C drug while England deliberates
Piotr Ozieranski et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis
Cristina Morciano et al.
PLOS ONE (2016)
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines
Holger J. Schunemann et al.
ANNALS OF INTERNAL MEDICINE (2015)
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise
Holger J. Schuenemann et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2014)
Systematic Analysis Underlying the Quality of the Scientific Evidence and Conflicts of Interest in Gastroenterology Practice Guidelines
Joseph D. Feuerstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Conflicts of interest and the quality of recommendations in clinical guidelines
Lisa Cosgrove et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2013)
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients
Jeanne Lenzer et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography
Susan L. Norris et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Medical Practice Guidelines as Malpractice Safe Harbors: Illusion or Deceit?
Maxwell J. Mehlman
JOURNAL OF LAW MEDICINE & ETHICS (2012)
Conflict of Interest Policies for Organizations Producing a Large Number of Clinical Practice Guidelines
Susan L. Norris et al.
PLOS ONE (2012)
Level of Scientific Evidence Underlying Recommendations Arising From the National Comprehensive Cancer Network Clinical Practice Guidelines
Thejaswi K. Poonacha et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process
L. Johnson et al.
JOURNAL OF MEDICAL ETHICS (2009)
Influence of industry on renal guideline development
Daniel W. Coyne
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
An elementary interpretation of the Gini inequality index
S Subramanian
THEORY AND DECISION (2002)
Relationships between authors of clinical practice guidelines and the pharmaceutical industry
NK Choudhry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)